- Shopping Bag ( 0 items )
From The CriticsReviewer: Cooper Woods, Ph.D.(Ochsner Clinic Foundation)
Description: This book provides a clear presentation of the use of biomarkers in the diagnosis and treatment of cardiovascular diseases. Especially appealing is the format which divides the biomarkers into seven classes, introducing the biological background for each class and then examining the individual members of the class more closely.
Purpose: The author seeks to provide clinicians with an authoritative book on the current state-of-the art in cardiovascular biomarkers. The book provides background on the reasons behind the development of the current biomarkers in a logical format that makes the material easily accessible.
Audience: It is aimed at practicing cardiologists and does an excellent job of defining the development and use of the current set of cardiovascular biomarkers as well as providing insight into the future directions of the field. A clear strength of the book is that the author has pulled together a first-class team of authors to present a complicated and diverse field in a well structured and comprehensible style.
Features: The book has broken down the current set of cardiovascular biomarkers into seven major classes. This format makes the material accessible while covering very diverse areas of biology. Strengths of the book include the chapters on necrosis, inflammation, and hemodynamic stress where a thorough analysis of the currently used biomarkers is presented. The chapters on ischemia, hemostasis, and dyslipidemia provide insight into the potential future role of biomarkers in these areas. A final chapter provides an overview of the methods used to develop cardiovascular biomarkers.
Assessment: This book presents a complicated subject in a well organized and thorough manner, providing the clinician with valuable insight into the development of the biomarkers currently in use and the future directions of the field.